Unlocking the Charms of Happy Valley: A Glimpse into Central Pennsylvania's Tourism Landscape

Hear from one student who landed a highly-coveted Silicon Valley job after getting the experience he needed from Happy Valley — all remotely This fall, students around the world debated whether to attend classes in a brick-and-mortar institution or take classes virtually. For one group of learners, the decision was easy: enroll in a school […]

Five-year-old, Happy Valley-based Warlowe is owned by Chris Wharton and Zack Lowe, two electrical engineers who met on the job and saw a need in the local market for individualized electrical engineering expertise.  “Many companies don’t have the budget to have a full engineering team on staff,” Wharton said. “We wanted to fill in those […]

A Cisco survey reports that 74% of IoT efforts fail. LNS Research goes even further, saying that only 8% of industrial digital transformation efforts achieve “real success.” Why? “Industry 4.0 is so new, the story is being written while it’s unfolding,” says Jacob Loverich, Chief Technology Officer at KCF Technologies. “American manufacturers want to keep pace or outpace steep international competition. They know […]

In this issue’s feature on Minitab, you heard how the company invests in recruiting and retaining the best employees. Last week’s issue featured two recent Penn State engineering grads who shared how they landed their dream careers in a dream location: Happy Valley. Now, we want to hear from you. Take our 5-question Talent Survey […]

Photo Credit: Patrick Mansell Penn State’s research expertise is undeniable. Last year, the university’s research expenditures exceeded $1 billion and, according to the National Science Foundation, Penn State surpasses all other universities in the country when it comes to research expenditures by key fields and subfields. Last year’s funding came from a variety of sources, […]

While you’re reading this, pharmaceutical companies are testing and developing over 400 different drugs and vaccines to fight infectious diseases ranging from HIV to tuberculous to COVID-19. Many of these drugs you will not hear about for another decade. During this early testing phase—years before these drugs are ready for the public or even ready […]